Trial Profile
Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions; Therapeutic Use
- 31 Jan 2017 New trial record